Credit: Scott Bodell/MedicalImages.com The authors outline preventative pharmacologic therapies for COPD exacerbations and a patient-tailored approach to management. Chronic obstructive pulmonary ...
Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...
Most chronic obstructive pulmonary disease (COPD) exacerbations were observed in those not treated with controller medications, but less than half of patients in the study received controller ...
Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
According to a recent study, patients with an exacerbation of chronic obstructive pulmonary disease (COPD) have greater risks of both subsequent exacerbations and mortality. The odds of subsequent ...
—Theses investigators found an increased risk for both individual and composite cardiovascular events following exacerbations of COPD, with sustained risk after 1 year regardless of severity. Reviewed ...
Woman suffering an anxiety attack alone in the night How does a delay in initiating triple therapy affect patients with COPD with a history of several moderate COPD exacerbations during a 1-year ...
In patients with chronic obstructive pulmonary disease (COPD), increasing frequency and severity of exacerbations were linked to a higher risk of future exacerbations and all-cause and COPD-related ...
Findings suggest that patients with COPD should be closely monitored for the risk of acute cardiovascular (CV) events following COPD exacerbations, and prevention of exacerbations should be a major ...
Treatment with dupilumab was associated with a 34% reduction in moderate or severe acute COPD exacerbations over 52 weeks compared with placebo. Treatment with dupilumab significantly reduced ...
—After severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD), certain physical function tests that are routinely performed at discharge fail to reflect the true patient ...
Poor quality of sleep was found to have a strong association with symptomatic exacerbations of chronic obstructive pulmonary disease, according to a recent Canadian study presented at the 2016 ...